|
Beware Early Warning System for Drug Shortages, Expert Urges Senate
If Congress mandates early alerts about drug shortages, implementation should get close monitoring and there should be audits of the FDA process for collecting data from drugmakers, an expert tells senators.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives